A Personal Blog
by Michael Froomkin
Laurie Silvers & Mitchell Rubenstein Distinguished Professor of Law
University of Miami School of Law
My Publications | e-mail
All opinions on this blog are those of the author(s) and not their employer(s) unelss otherwise specified.
Who Reads Discourse.net?
Readers describe themselves.
Please join in.Reader Map
Recent Bluessky Posts- Jotwell Int'l: Kathleen Claussen, International Regulatory Geopolitics, JOTWELL (9/9/26) (reviewing Lucian Cernat & Hannah Preuss, Soft Power, Hard Standards: How Strong Is the 'Brussels Effect' in International Standards?, __ J. World Trade __ (forthcoming 2026)), intl.jotwell.com/internationa.... September 9, 2026 Jotwell
- Official CFP for We Robot in Oxford, UK, April 22-24, 2027 is now available at easychair.org/cfp/WR27. Submission deadline is Oct. 5, 2026. Also, AI disclosure requested and "papers may be reviewed by AI detection, whose feedback will be instructive but not determinative." September 8, 2026 Michael Froomkin
- For a chilling analysis of where we stand see Professor Kim Lane Scheppele on "What is a Constitutional Crisis?". And that was almost a year ago! www.youtube.com/watch?v=g-8A... September 8, 2026 Michael Froomkin
- @miamilawschool.bsky.social does a feature on @jotwell.bsky.social, "Jotwell: the journal legal scholars turn to for research that matters" news.miami.edu/law/stories/... September 8, 2026 Michael Froomkin
- Private right of action (in court) vs government-must-initiate enforcement (before court or via agency). So the difference from the econ or polisci dichotomy is less than it may seem? September 8, 2026 Michael Froomkin
Recent Comments
Subscribe to Blog via Email
Join 53 other subscribers
Monthly Archives: February 2021
This
Posted in Trump
8 Comments
More Evidence that the State of Florida Just Isn’t Into this COVID-Control Stuff (Updated)
The Florida Bulldog reports,
Florida is dismissing a recent warning from federal regulators about the accuracy of a popular COVID-19 test from one of the state’s largest testing providers — and continuing to use the test in a way the FDA has advised against.
Meanwhile, the state’s most populous county, Miami-Dade, is reconsidering how it uses the test.
The U.S. Food and Drug Administration issued a warning last month alerting the public to “the risk of false results, particularly false negative results,” with the test made by an enormous San Dimas, CA-based testing start-up, Curative, noting that false negatives can mean people unknowingly spreading the virus to others. The risk of false negatives is higher, the FDA noted, when the test isn’t used correctly.
Lots more at Florida defies FDA warning on controversial COVID test with off-label use, but Miami-Dade reconsiders.
Update: a friend writes to suggest the Curative test is really OK and doesn’t deserve the bastinado.
